With no active resistance this time around from Ron Burkle’s Yucaipa, Barnes & Noble shareholders officially and “overwhelmingly” ratified the company’s poison pill plan, with 72 percent of votes cast in favor. Separately, in a periodic SEC filing, Aletheia Research & Management indicated that they have continued to trim their position in Barnes & Noble’s stock, they though still hold a substantial stake comprising just over 14 percent of all shares. In the past two months, they had a net sale of approximately 635,000 shares, now down to roughly 8.4 million shares as of November 10 after holding about 9.05 […]
